Skip to content
healthcare.dev

cilostazol

NDC 60505-2522, cilostazol, tablet, from Apotex Corp..

Product NDC
60505-2522
Status
Listed
Labeler
Apotex Corp.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077030
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-2522 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CILOSTAZOL100 mg/1

Pharmacologic classes

Phosphodiesterase 3 Inhibitor [EPC]; Phosphodiesterase 3 Inhibitors [MoA]

Package NDCNDC-11Package
60505-2522-16050525220160 TABLET in 1 BOTTLE (60505-2522-1)
60505-2522-36050525220330 TABLET in 1 BOTTLE (60505-2522-3)
60505-2522-8605052522081000 TABLET in 1 BOTTLE (60505-2522-8)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ceac1ae3-c343-28ca-c083-b748d21a15e6
  • NADAC price for package 60505252201

    GET /v1/drugs/nadac/60505252201

Use it

Look up 60505-2522 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-2522 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-2522. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.